Type 1 diabetes charity reacts to Animas insulin pump discontinuation

A sort 1 diabetes charity has issued recommendation on coping with the “concerning” information particular model of insulin pump is now not out there. JDRF has stated it’s “monitoring the situation” and is urging folks to contact their healthcare workforce in a bid to guarantee a clean transition to one other model of pump. Animas, the second-largest producer of insulin pumps, has confirmed manufacturing of the Animas Vibe or OneTouch Ping within the UK and Ireland will stop instantly. The information will come as a disappointment to individuals who use these merchandise, though is not going to be an entire shock because the agency ended gross sales and manufacturing final yr within the US, asserting the UK would ultimately comply with. Responding to the information, JDRF’s UK chief government officer (CEO) Karen Addington, launched a press release citing the charity’s disappointment. She stated: “This news is concerning and JDRF is monitoring the situation. It’s important that users are supported by Animas and their healthcare team to identify an alternative pump and ensure a smooth transition to a new medical device.” Animas stated it’s presently within the means of contacting all its prospects issuing recommendation about what they need to do subsequent when contemplating therapy choices. The firm has dedicated to honouring pump warranties and a assist and care workforce remains to be in place to assist with folks’s transition plans. Patients who use LifeScan, Dexcom or Diasend merchandise can proceed to accomplish that and Animas has stated the identical buyer care will probably be in place. Medtronic has been chosen as Animas’ companion to assist facilitate a “seamless insulin delivery system transition period”. For anybody who wants additional recommendation the Animas buyer assist workforce may be contacted on 0800 028 8039 within the UK or 1800 812 715 within the Republic of Ireland, or alternatively ebook an appointment to communicate with their healthcare workforce.